Skip to main content
TipRanks
Go Ultimate75% OFF

Esprinet Spa (PRT) AI Stock Analysis

7 Followers
IT:PRT

Esprinet Spa

(Milan:PRT)

Select Model
Rating:51Neutral
Price Target:EUR 6.00â–¼(-0.74% Downside)
Action:reiterated
Date:11/14/26

The score is held back mainly by weak financial quality—especially the sharp swing to negative operating/free cash flow and higher leverage—along with bearish price momentum below key moving averages. These negatives are partially offset by a moderate P/E and a high dividend yield, plus recent stabilization in revenue and a return to modest profitability.

Positive Factors
Revenue RecoveryThe return to revenue growth indicates that Esprinet has regained some demand and channel traction after the 2023 downturn. Continued stabilization would support operating scale, strengthen its role with resellers and vendors, and provide a foundation for improving earnings over the next several quarters.
Negative Factors
Negative Cash GenerationNegative operating and free cash flow is a material weakness because distribution businesses require liquidity to support inventory and customer working capital. The reversal from positive 2025 cash flow can constrain investment, increase reliance on financing, and make earnings less useful as a measure of financial strength.

Esprinet Spa (PRT) vs. iShares MSCI Italy ETF (EWI)

-40%-20%0%20%40%60%80%IT:PRT+13.35%EWI+14.61%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 319.89M
Dividend Yield
5.78%
Average Volume (3M)
204.70K
Price to Earnings (P/E)
13.8
Beta (1Y)
0.86
Revenue Growth
7.91%
EPS Growth
5.86%
Country
Italy
Employees
1,880
Sector
General
Sector Strength
55
Industry
Technology Distributors

Esprinet Spa Business Overview & Revenue Model

Company Description

Esprinet S.p.A., headquartered in Vimercate, Italy, operates as a leading wholesale distributor of information technology (IT) and consumer electronics. Its primary markets include Italy, Spain, Portugal, and other European countries. The company's e...

How the Company Makes Money

Esprinet mainly makes money by purchasing IT and consumer electronics products from manufacturers and brand owners (vendors) and reselling them to business customers (primarily resellers/retailers/system integrators) at a markup, generating gross pro...

Esprinet Spa Financial Statement Overview

Summary

Financials are mixed. Revenue has stabilized and returned to modest growth and profitability versus the 2023 downturn, but margins remain very thin (TTM net margin ~0.5%, operating margin ~1.2%). The biggest drag is cash generation: TTM operating cash flow (~-€71M) and free cash flow (~-€77M) are negative, alongside higher leverage (debt-to-equity ~1.18 vs ~0.71 in 2025), reducing flexibility.

Income Statement

62Positive

Balance Sheet

55Neutral

Cash Flow

38Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.59B4.29B4.14B3.99B4.68B4.69B
Gross Profit252.30M235.07M226.94M218.44M242.97M231.89M
EBITDA73.93M71.12M68.82M35.82M86.93M83.05M
Net Income22.32M20.17M21.52M-11.88M47.35M44.18M
Balance Sheet
Total Assets1.97B2.08B2.02B1.84B1.87B1.92B
Cash, Cash Equivalents and Short-Term Investments200.67M230.78M216.35M261.00M172.19M491.47M
Total Debt494.41M278.00M262.28M249.00M265.68M273.81M
Total Liabilities1.59B1.69B1.63B1.47B1.47B1.54B
Stockholders Equity380.52M389.47M389.25M367.41M409.22M386.12M
Cash Flow
Free Cash Flow-77.26M45.98M-3.20M154.55M-263.84M15.81M
Operating Cash Flow-71.46M49.32M2.77M168.04M-251.41M21.65M
Investing Cash Flow-26.50M-24.55M-5.61M-19.95M-19.06M-17.02M
Financing Cash Flow157.27M-10.46M-41.80M-59.39M-48.82M-72.09M

Esprinet Spa Technical Analysis

Technical Analysis SentimentNegative
Last Price6.04

Price Trends

50DMA7.75Negative
100DMA7.43Negative
200DMA6.65Negative

Market Momentum

MACD-0.33Positive
RSI22.32Positive
STOCH24.27Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:PRT, the sentiment is Negative. The current price of 6.04 is below the 20-day moving average (MA) of 7.41, below the 50-day MA of 7.75, and below the 200-day MA of 6.65, indicating a bearish trend. The MACD of -0.33 indicates Positive momentum. The RSI at 22.32 is Positive, neither overbought nor oversold. The STOCH value of 24.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:PRT.

Esprinet Spa Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IT:PRT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IT:DLGIT:DLG83OutperformEUR 7.14B14.7224.09%2.68%6.43%7.10%
IT:BECIT:BEC71OutperformEUR 118.71M13.5015.88%6.48%-9.46%-22.96%
IT:SESIT:SES68NeutralEUR 1.45B19.2916.11%1.44%10.60%18.44%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IT:PRTIT:PRT51NeutralEUR 330.25M13.825.61%5.78%7.91%5.86%
IT:ETHIT:ETH44NeutralEUR 76.32M-9.35-10.59%―14.99%87.84%

* General Sector Average

Performance Comparison

-50%0%50%IT:PRTIT:BECIT:EPHIT:DLGIT:ETHIT:SESDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IT:PRT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IT:PRTEsprinet Spa6.040.7814.75%
IT:BECB&C Speakers S.p.A.10.80-3.34-23.63%
IT:EPHePRICE S.p.A.1.51-8.09-84.27%
IT:DLGDe'Longhi S.p.A.47.4014.0342.05%
IT:ETHEurotech S.p.A.1.280.3740.11%
IT:SESSesa S.p.A.92.6010.5212.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026